Blog Posts Multiplex Molecular Testing: What are the key considerations for reducing denials in molecular multiplex panel testing under MolDx and broader payer policy requirements 08/14/2026 An expert perspective from Ann Lambrix, Executive Director, RCM Consulting on the evolving multiplex molecular reimbursement landscape and what laboratories … Read More
